
Opinion|Videos|October 30, 2025
ClipNotes: AI Built for Pharma: Why Out-of-the-Box Beats Build-From-Scratch Clip 3
Advertisement
Key moments from the Pharmaceutical Executive webcast:
- Buy the validated floor. Build only the edge.
See how leading teams are achieving measurable impact in just 90 days—without adding validation debt or manual, swivel-chair workflows. Purpose-built, inspection-ready platforms now outpace custom builds on speed, auditability, and Veeva/SFDC interoperability—driving faster adoption and tangible results.
Watch three key moments below, then
To read the full executive summary,
KEY MOMENT 3
Interoperability Isn’t a Nice-to-Have
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly Enters $202 Million Agreement to Acquire Engage Bio
2
Eli Lilly and Novo Nordisk Shift Patients From Compounded Drugs to Lower-Cost Weight-Loss Pills: Report
3
FDA Approves Datroway for Patients with Metastatic Triple-Negative Breast Cancer Who Are Not PD-1/PD-L1 Inhibitor Candidates
4
The Evolving Relationship Between FDA and Biotech
5
